psalexa
SearchBar Icon

Biosimilars Market By Product (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Technology (mAb, rDNA, Bioassays, Nuclear Magnetic Resonance, Electrophoresis), Indication (Oncology, Rheumatology, Blood-Related Disorders, Auto-Immune Diseases, Chronic Diseases, Infectious Diseases, Growth Hormone Deficiency), Route of Administration (Intravenous, Subcutaneous, Intranasal), Geographical Outlook – Trends Analysis and Growth Forecast to 2024

Published Report Code Available Format Pages
 April 2019  LS10997    187

Place an order

USD 4900
USD 5900
USD 7500
We use cookies to enhance your experience. By continuing to use this site you consent to our use of cookies. More info X